Treatment of hepatitis C virus genotype 4 in the DAA era
Abstract The recently approved interferon-free DAA (direct antiviral agents) regimens have shown not only to be effective in terms of sustained virological response (SVR) rates (> 90%) but also well tolerated in most hepatitis C virus (HCV) infected patients. Nevertheless HCV genotypes are differ...
| Main Authors: | , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMC
2018-11-01
|
| Series: | Virology Journal |
| Online Access: | http://link.springer.com/article/10.1186/s12985-018-1094-4 |